Beta Blocker Use Increases The Risk of Perioperative Cardiac Events in Liver Transplant Patients

Background: Recent evidence has linked beta blocker (BB) use with perioperative major adverse cardiovascular events (MACE) after non-cardiac surgery. BB are often used for treatment of portal hypertension in liver disease. We sought to determine whether BB use was associated with adverse perioperative outcomes in liver transplantation (LT).
Source: Heart, Lung and Circulation - Category: Cardiology Authors: Tags: 354 Source Type: research